首页> 外文OA文献 >DNMT3A R882 Mutation with FLT3-ITD Positivity Is an Extremely Poor Prognostic Factor in Patients with Normal-Karyotype Acute Myeloid Leukemia after Allogeneic Hematopoietic Cell Transplantation

【2h】

DNMT3A R882 Mutation with FLT3-ITD Positivity Is an Extremely Poor Prognostic Factor in Patients with Normal-Karyotype Acute Myeloid Leukemia after Allogeneic Hematopoietic Cell Transplantation

机译：DNMT3A R882突变与FLT3-ITD阳性是同种异体造血细胞移植后正常核型急性髓性白血病患者的极差预后因素。

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Ahn Jae-Sook; Kim Hyeoung-Joon; Kim Yeo-Kyeoung; Lee Seun-Shin; Jung Sung-Hoon; Yang Deok-Hwan; Lee Je-Jung; Kim Nan Young; Choi Seung Hyun; Jung Chul Won; Jang Jun-Ho; Kim Hee Je; Moon Joon Ho; Sohn Sang Kyun; Won Jong-Ho; Kim Sung-Hyun; Kim Dennis Dong Hwan;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. DNMT3A R882 Mutation with FLT3-ITD Positivity Is an Extremely Poor Prognostic Factor in Patients with Normal-Karyotype Acute Myeloid Leukemia after Allogeneic Hematopoietic Cell Transplantation [J] . Ahn Jae-Sook, Kim Hyeoung-Joon, Kim Yeo-Kyeoung, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2016,第1期

机译：DNMT3A R882突变与FLT3-ITD阳性是同种异体造血细胞移植后正常核型急性髓性白血病患者的极差预后因素。
2. FLT3-ITD with DNMT3A R882 double mutation is a poor prognostic factor in Chinese patients with acute myeloid leukemia after chemotherapy or allogeneic hematopoietic stem cell transplantation [J] . Shanhao Tang, Hongjie Shen, Xinliang Mao, International journal of hematology . 2017,第4期

机译：FLT3-ITD与DNMT3A R882双突变是化疗或同种异体造血干细胞移植后中国急性髓性白血病患者的不良预后因素
3. The impact of DNMT3A/FLT3-ITD/NPM1 on patients with acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation [J] . Long Su Turkish Journal of Hematology . 2019,第1期

机译：双生共生造血干细胞移植后DNMT3A / FLT3-ITD / NPM1对急性髓性白血病患者的影响
4. Intravenous Busulfan Reduces Toxicity Associated with Myeloablative Allogeneic Hematopoietic Transplantation in Patients with Myeloid Malignancies [C] . A. Shimoni, B. Bxelorai, I. Hardan, European Haematology Association . 2002

机译：静脉内的伯鲁兰减少骨髓恶性肿瘤患者患有髓鞘异产造血移植的毒性
5. Genetic Associations in Acute Leukemia Patients After Matched Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation [D] . Rizvi, Abbas A. 2019

机译：匹配的无关供体同种异体造血干细胞移植后急性白血病患者的遗传协会。
6. FLT3-ITD Compared with DNMT3A R882 Mutation Is a More Powerful Independent Inferior Prognostic Factor in Adult Acute Myeloid Leukemia Patients After Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Cohort Study [O] . Majid Teremmahi Ardestani, Ahmad Kazemi, Bahram Chahardouli, 2018

机译：同种异体造血干细胞移植后FLT3-ITD与DNMT3A R882相比突变是成年急性髓细胞性白血病患者中更强大的独立不良预后因素：一项回顾性队列研究
7. FLT3-ITD compared with DNMT3A R882 mutation is a more powerful independent inferior prognostic factor in adult AML patients after Allogeneic Hematopoietic Stem Cell Transplantation: A retrospective cohort study [O] . Majid Teremmahi Ardestani, Ahmad Kazemi, Bahram Chahardouli, 2018

机译：FLT3-ITD与DNMT3A R882突变相比，同种异体造血干细胞移植后成人AML患者的一个更强大的独立劣质预后因素：回顾性队列研究

DNMT3A R882 Mutation with FLT3-ITD Positivity Is an Extremely Poor Prognostic Factor in Patients with Normal-Karyotype Acute Myeloid Leukemia after Allogeneic Hematopoietic Cell Transplantation

著录项

引文网络

相似文献

相关主题

期刊订阅